Provided by Tiger Trade Technology Pte. Ltd.

XORTX Therapeutics Inc.

1.72
+0.310021.99%
Pre-market: 1.58-0.1400-8.14%07:29 EDT
Volume:1.76M
Turnover:3.02M
Market Cap:3.12M
PE:-0.61
High:1.90
Open:1.40
Low:1.39
Close:1.41
52wk High:7.05
52wk Low:1.36
Shares:1.82M
Float Shares:1.79M
Volume Ratio:0.30
T/O Rate:98.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8252
EPS(LYR):-2.8052
ROE:-99.24%
ROA:-29.85%
PB:0.57
PE(LYR):-0.61

Loading ...

Xortx Therapeutics Shares Rise After Company Reports Potential Partner Interest for Gout Program

MT Newswires Live
·
Oct 09

XORTX Therapeutics Shares Rise 23% Above $2 After the Bell Following Update on Health Canada Clinical Trial Application of Treatment for Gout

THOMSON REUTERS
·
Oct 09

Xortx Therapeutics outlines anticipated clinical trial application for XRx-026

TIPRANKS
·
Oct 09

XORTX Plans Health Canada Filing to Launch XRx-026 Gout Trial in Canada

Reuters
·
Oct 09

XORTX Therapeutics - First Part of Xrx-Oxy-102 Study in Canada Expected to Accelerate Nda Filing with FDA

THOMSON REUTERS
·
Oct 09

XORTX Therapeutics - Receives Increased Inquiries from Potential Commercialization Partners for Xrx-026

THOMSON REUTERS
·
Oct 09

XORTX Outlines Anticipated Health Canada Clinical Trial Application for Xrx-026 for Gout

THOMSON REUTERS
·
Oct 09

Xortx Therapeutics announces planned FDA IND submission for XRx-026

TIPRANKS
·
Sep 18

XORTX Plans Q4 2026 FDA IND Filing for XRx-026 Gout Trial Using Xorlo, Targets USD 700 Million U.S. Market

Reuters
·
Sep 18

XORTX Therapeutics - to Submit Ind to FDA in Q4 2026

THOMSON REUTERS
·
Sep 18

XORTX Therapeutics - Announces Initiation of Drug and Tablet Manufacturing for Xrx-026 Program

THOMSON REUTERS
·
Sep 11

XORTX Starts GMP Manufacturing for XORLO to Support XRX-OXY-102 Gout Trial

Reuters
·
Sep 11

XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO™

GlobeNewswire
·
Sep 11

XORTX Announces Termination and Postponement of Investor Relations Program

GlobeNewswire
·
Aug 28

XORTX Announces Director Resignation

GlobeNewswire
·
Aug 01

Press Release: XORTX Appoints New Director

Dow Jones
·
Jul 29

Xortx Therapeutics announces Mika Grasso as co-CEO

TIPRANKS
·
Jun 15

XORTX Provides Corporate Update and Announces Appointment of Mika Grasso as Co-CEO

GlobeNewswire
·
Jun 15

XORTX Announces Election to Voluntary Delist from the TSX Venture Exchange

GlobeNewswire
·
Jun 13

XORTX Announces Closing of US$5 Million Public Offering

GlobeNewswire
·
May 19